The role of the EORTC pathologist in clinical trials: achievements and perspectives

This publication has 35 references indexed in Scilit:

• Quality assurance in surgical oncology (QASO) within the European Organization for Research and Treatment of Cancer (EORTC): current status and future prospects
  European Journal Of Cancer, 2001
• Prognostic Factors in Primary Cutaneous Large B-Cell Lymphomas: A European Multicenter Study
  Journal of Clinical Oncology, 2001
• Variations in diagnostic and therapeutic procedures in a multicentre, randomized clinical trial (EORTC 10853) investigating breast-conserving treatment for DCIS
  European Journal of Surgical Oncology, 2001
• Pathology Data in the Central Databases of Multicenter Randomized Trials Need to Be Based on Pathology Reports and Controlled by Trained Quality Managers
  Journal of Clinical Oncology, 2000
• Prognostic factors in patients with pleural mesothelioma: the European Organization for Research and Treatment of Cancer experience.
  Journal of Clinical Oncology, 1998
• Melanoma in childhood: An EORTC-MCG multicenter study on the clinico-pathological aspects
  International Journal of Cancer, 1996
• Central pathology review in clinical trials for patients with malignant glioma. A report of radiation therapy oncology group 83-02
  Cancer, 1995
• Stage I melanoma of the skin: Evaluation of prognosis according to histologic characteristics
  Cancer, 1981
• Estrogen receptor status and response to polychemotherapy in advanced breast cancer
  Cancer, 1980
• An assay for estradiol receptors using a staphylococcal protein-a — estradiol antibody adsorbent
  International Journal of Cancer, 1979